Condition (MeSH)
Auditory Diseases, Central
ClinicalTrials.gov lists 28 trials for Auditory Diseases, Central or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 28 trials are tagged with Auditory Diseases, Central itself; the rest are tagged with a narrower condition beneath it.
When did Auditory Diseases, Central trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 1 |
| 2020 | 3 |
| 2019 | 1 |
| 2018 | 4 |
| 2016 | 2 |
| 2015 | 2 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Auditory Diseases, Central trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 4 | 1 |
| Not applicable | 19 |
| Observational | 7 |
How many Auditory Diseases, Central trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 16 |
| Terminated | 4 |
| Withdrawn | 1 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Auditory Diseases, Central trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute on Deafness and Other Communication Disorders (NIDCD) | 3 |
| VA Office of Research and Development | 3 |
| US Department of Veterans Affairs | 1 |
Which drugs are being tested for Auditory Diseases, Central? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| PROPOFOL | 1 |
Interventions as named in the registry (3)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Clemastine Fumarate Combined With Pink Noise | 1 |
| Hormone Replacement Therapy - HRT | 1 |
| Sham device | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Auditory Diseases, Central trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Middle ear infection and mass | 1 | 1 |
Which publications cover Auditory Diseases, Central? (8)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Latent iron deficiency at birth influences auditory neural maturation in late preterm and term infants. | The American journal of clinical nutrition | 2015 | Yes |
| Nutrition and hearing loss: a neglected cause and global health burden. | The American journal of clinical nutrition | 2015 | Yes |
| Implications of blast exposure for central auditory function: a review. | Journal of rehabilitation research and development | 2012 | Yes |
| MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder. | Neurobiology of disease | 2012 | Yes |
| Multi-site diagnosis and management of 260 patients with auditory neuropathy/dys-synchrony (auditory neuropathy spectrum disorder). | International journal of audiology | 2010 | Yes |
Showing 5 of 8 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.